Specifics. The parties shall agree to execute the necessary documents to create common ownership of the T1 and T2 patent families in the United States. When common ownership is established, except as provided for herein, no party may dedicate to the public or convey to any other party by assignment, license or otherwise any interest that they acquired in T2 nor may they make any statements that T2 intellectual property is free to be used for research purposes.
Appears in 2 contracts
Sources: Confidential Settlement Agreement (Alnylam Pharmaceuticals, Inc.), Confidential Settlement Agreement and Mutual Release (Alnylam Pharmaceuticals, Inc.)